Investor Type | Firm |
Type of Fund | Private Equity Fund |
Industries | Cannabis • Food & Beverage • Logistics (& Distribution) |
Stages | Expansion |
Investing | United States • Israel • Europe |
Assets Under Management | $250,000,000 |
Entourage Effect Capital, previously known as Cresco Capital Partners, is a private equity investment firm that focuses on the cannabis industry. Established in 2014 and headquartered at 8214 Westchester Dr., Suite 850, Dallas, Texas, the firm is actively involved in nurturing the growth of burgeoning companies within the cannabis space. They possess a deep understanding of the market dynamics and regulatory environments in which these companies operate. The firm's investment thesis is grounded on the significant growth potential that the cannabis industry presents as more regions are legalizing its use for medical and recreational purposes. Entourage Effect Capital targets investments across a wide spectrum of the cannabis industry, which includes, but is not limited to, companies involved in cultivation, processing, distribution, retail, technology, and ancillary services. With a specialization in expansion, they offer both debt and equity financing options to companies looking to scale their operations. Recognizing the unique challenges and opportunities within the cannabis sector, their aim is to partner with companies that are well-positioned to capitalize on the evolving legal landscape and increasing consumer demand. Entourage Effect Capital manages assets worth approximately $250 million, underlining its substantial commitment to and belief in the long-term viability of the industry. Their investments are characterized by a strategic approach that leverages the firm's sector-specific expertise to drive value for their portfolio companies and deliver robust returns for their investors. The firm is characterized by its dedication to leading the charge in an emergent industry that has the potential to revolutionize health, wellness, and leisure activities worldwide.